Peripartum measurements. Descriptives of women with hs-cTNT > 5 ng/l (n= 65) and women with NTproBNP > 125 ng/l (n=18) at the peripartum measurement compared to women with low levels.
| Variable | Hs-cTNT≤5 | Hs-cTNT>5 | NTproBNP≤125 | NTproBNP>125 | ||
| (n=54) | (n=65) | p-value | (n=102) | (n=18) | p-value | |
| Age, (mean, SD) | 31.19 (4.74) | 30.78 (4.22) | 0.627 | 30.90 (4.36) | 31.56 (5.03) | 0.568 |
| eGFR, (mean, SD) | 103.00 (12.58) | 100.77 (10.56) | 0.291 | 102.48 (10.81) | 96.50 (14.23) | 0.042 |
| Time to blood test, (median, IQR) | 29.00 (18.00) | 22.25 (15.50) | 0.001 | 26.00 (16.00) | 26.50 (20.75) | 0.906 |
| Systolic BP,* (mean, SD) | 116.66 (7.36) | 118.58 (9.13) | 0.222 | 117.79 (8.57) | 116.69 (7.11) | 0.627 |
| Diastolic BP,* (mean, SD) | 67.81 (6.72) | 68.68 (7.96) | 0.534 | 68.51 (7.57) | 67.00 (5.99) | 0.449 |
| Cardiac Index,* (mean, SD) | 3.08 (.49) | 3.05 (.52) | 0.779 | 3.07 (.52) | 3.02 (.39) | 0.7330 |
| IVF (%) | 0.454 | 1.000 | ||||
| No | 52 (96) | 60 (92) | 96 (94) | 17 (94) | ||
| Yes | 2 (4) | 5 (8) | 6 (6) | 1 (6) | ||
| Peripartum oxytocin, n (%) | 0.116 | 0.003† | ||||
| No | 5 (9) | 5 (8) | 0.735 | 7 (7) | 3 (17) | 0.170 |
| Yes, labour augmentation | 13 (25) | 28 (43) | 0.035 | 30 (30) | 11 (61) | 0.010 |
| Yes, prophylaxis only | 35 (66) | 32 (49) | 0.067 | 64 (63) | 4 (22) | 0.001 |
| Delivery Mode, n (%) | 0.116 | 0.001 | ||||
| Spontaneous vaginal | 43 (80) | 58 (89) | 0.150 | 92 (90) | 10 (56) | 0.001 |
| Other | 11 (20) | 7 (11) | 0.130 | 10 (10) | 8 (44) | 0.001 |
*measured at time point B (20-25 gw). “Other” delivery mode was assisted vaginal or cesarean section
†Bonferroni-adjusted comparisons were calculated between hs-cTNT and peripartum medications and NTproBNP and peripartum medications. The Bonferroni-adjusted p-value was set to .0083.